Access cutting-edge colorectal cancer treatment through this clinical trial at a research site in Philadelphia. Study-provided care at no cost to qualified participants.
Access colorectal cancer specialists in Philadelphia at no cost
This study follows strict safety protocols and ethical guidelines
All study-related colorectal cancer treatment provided free
The performance of SGM-101, an intraoperative imaging agent, will be compared to that of standard "white light" visualization during surgical resections of colorectal cancer.
Sponsor: Surgimab
Check if you qualify for this colorectal cancer clinical trial in Philadelphia, PA
If you're searching for colorectal cancer treatment options in Philadelphia, PA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Philadelphia research site is actively enrolling participants for this clinical trial. You'll receive care from experienced colorectal cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.